ArticleCureus2025
Association of Fat Mass and Obesity (FTO) rs9939609 Single Nucleotide Polymorphism (SNP) With Obesity and Type 2 Diabetes (T2D) in Healthy Young Adults in Kuwait.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe aim was to determine the association of the common fat mass and obesity-associated (FTO) gene polymorphism rs9939609 with the risk of developing obesity and type 2 diabetes (T2D) in healthy young university students in Kuwait.
methodsThis cross-sectional study included 201 students from Kuwait University (males = 99; females = 102). The author analyzed the association of FTO and obesity using the body mass index (BMI) as a binary categorical variable (non-obese-BMI < 25 vs. obese-BMI > 25) and the BMI as a continuous variable, using both logistic and linear regression models, respectively. Genotyping of the FTO rs9969609 was performed using the TaqMan single nucleotide polymorphism (SNP) Genotyping Assay (Applied Biosystems, Foster City, USA) and ABI 7500 Fast Real-Time PCR system SDS software (Life Technologies, California, USA) was used for allelic discrimination.
resultsBMI (continuous variable) was not associated with FTO in either the adjusted dominant genetic model (p = 0.33) or the additive model (p = 0.35). Similarly, neither the adjusted dominant (p = 0.66) nor the additive model (p = 0.39) showed FTO as a significant predictor of categorical BMI. In addition, the analysis showed that FTO was not a risk factor for T2D in either the adjusted dominant (p = 0.08) or the additive model (p = 0.17). The FTO allele frequency (%) in the study population (A: 44%; T: 56%) did not significantly differ from the global allele frequency (p-value > 0.05). As for genotype frequency distribution (%) in this study, FTO (AG: 37.8%; AA: 5.5%; GG: 56.7%) was found not to be in equilibrium with the Hardy-Weinberg Equation.
conclusionFTO is not a significant predictor of obesity or the future risk of T2D in healthy young adults of Kuwait. The cross-sectional genetic study design is a limitation for the detection or significant predictors of obesity or T2D among young adults in Kuwait.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.